Tuesday - March 17, 2026
Prior authorization bans for opioid treatment may not improve retention
March 10, 2026
ITHACA, New York, March 10 -- Cornell University posted the following news:

* * *

Prior authorization bans for opioid treatment may not improve retention

*

State laws that ban insurance prior authorization for buprenorphine - a leading medication for opioid use disorder - may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report.

Though prescription buprenorphin . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products